Form 8-K - Current report:
SEC Accession No. 0001193125-26-178718
Filing Date
2026-04-27
Accepted
2026-04-27 06:06:01
Documents
16
Period of Report
2026-04-26
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d38652d8k.htm   iXBRL 8-K 56632
2 EX-2.1 d38652dex21.htm EX-2.1 625015
3 EX-99.1 d38652dex991.htm EX-99.1 32838
7 GRAPHIC g38652dsp0001.jpg GRAPHIC 6252
8 GRAPHIC g38652dsp001a.jpg GRAPHIC 5708
9 GRAPHIC g38652dsp011b.jpg GRAPHIC 3920
  Complete submission text file 0001193125-26-178718.txt   1020071

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA ogn-20260426.xsd EX-101.SCH 3162
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE ogn-20260426_lab.xml EX-101.LAB 17992
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ogn-20260426_pre.xml EX-101.PRE 11250
19 EXTRACTED XBRL INSTANCE DOCUMENT d38652d8k_htm.xml XML 3630
Mailing Address 30 HUDSON STREET FL 33 JERSEY CITY NJ 07302
Business Address 30 HUDSON STREET FL 33 JERSEY CITY NJ 07302 551-430-6000
Organon & Co. (Filer) CIK: 0001821825 (see all company filings)

EIN.: 464838035 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40235 | Film No.: 26896382
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)